📰 Given Alpha Teknova News
Given Alpha Teknova News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Alpha Teknova. Real-time updates on events, politics, business and more.
June 23, 2023
Lucira Health (NASDAQ:LHDXQ – Get Rating) and Alpha Teknova (NASDAQ:TKNO – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership. Valuation and Earnings This table compares Lucira Health and […]
June 23, 2023
Lucira Health (NASDAQ:LHDXQ – Get Rating) and Alpha Teknova (NASDAQ:TKNO – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Earnings & Valuation This table compares Lucira Health and […]
June 21, 2023
Lucira Health (NASDAQ:LHDXQ – Get Rating) and Alpha Teknova (NASDAQ:TKNO – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Volatility & Risk Lucira Health has a beta of […]
May 22, 2023
Alpha Teknova (NASDAQ:TKNO – Get Rating) and Lucira Health (NASDAQ:LHDXQ – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Risk and Volatility Alpha Teknova has a beta of […]
April 10, 2023
Alpha Teknova (NASDAQ:TKNO – Get Rating) and Cardio Diagnostics (NASDAQ:CDIO – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Institutional & Insider Ownership 22.7% of Alpha Teknova shares […]
September 9, 2022
Alpha Teknova (NASDAQ:TKNO – Get Rating) and Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Earnings & Valuation This table compares Alpha Teknova and […]
June 13, 2022
Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 public companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Alpha Teknova to similar companies based on the strength of its profitability, dividends, earnings, institutional ownership, risk, analyst recommendations and valuation. Insider & Institutional Ownership 25.5% of […]
June 11, 2022
Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 public companies in the “Diagnostic substances” industry, but how does it weigh in compared to its rivals? We will compare Alpha Teknova to similar companies based on the strength of its earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk. Insider and Institutional Ownership […]
June 10, 2022
Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 publicly-traded companies in the “Diagnostic substances” industry, but how does it compare to its peers? We will compare Alpha Teknova to related businesses based on the strength of its dividends, risk, valuation, analyst recommendations, earnings, profitability and institutional ownership. Analyst Recommendations This is a breakdown […]
June 7, 2022
Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 public companies in the “Diagnostic substances” industry, but how does it compare to its peers? We will compare Alpha Teknova to similar companies based on the strength of its risk, profitability, valuation, earnings, analyst recommendations, dividends and institutional ownership. Institutional & Insider Ownership 25.5% of […]